Multiplexed protein profiling after aneurysmal subarachnoid hemorrhage: Characterization of differential expression patterns in cerebral vasospasm

Journal of Clinical Neuroscience

Volumn 21, Issue 12, 2014, Pages 2135-2139

  Walcott, Brian P ^a   Patel, Anoop P ^a   Stapleton, Christopher J ^a   Trivedi, Rikin A ^b   Young, Adam M H ^a,b   Ogilvy, Christopher S ^c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Aneurysm; Biomarker; Subarachnoid hemorrhage; Vasospasm

Indexed keywords

ALPHA 2 MACROGLOBULIN; ANGIOGENIN; APOLIPOPROTEIN A4; BIOLOGICAL MARKER; GRANULOCYTE COLONY STIMULATING FACTOR; MACROPHAGE ACTIVATING FACTOR; NIMODIPINE; TETRANECTIN; VASCULOTROPIN RECEPTOR 3; VITRONECTIN; A2M PROTEIN, HUMAN; APOLIPOPROTEIN A; APOLIPOPROTEIN A-IV; PANCREATIC RIBONUCLEASE;

ADULT; ARTICLE; BLOOD SAMPLING; BRAIN ISCHEMIA; BRAIN VASOSPASM; CLINICAL ARTICLE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTROLLED STUDY; FEMALE; HIGH RISK PATIENT; HUMAN; IMMUNOASSAY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; SUBARACHNOID HEMORRHAGE; BLOOD; BRAIN ANGIOGRAPHY; COMPLICATION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; METABOLISM; MIDDLE AGED; VASOSPASM, INTRACRANIAL;

ADULT; ALPHA-MACROGLOBULINS; APOLIPOPROTEINS A; CEREBRAL ANGIOGRAPHY; FEMALE; HUMANS; MIDDLE AGED; RIBONUCLEASE, PANCREATIC; SUBARACHNOID HEMORRHAGE; TOMOGRAPHY, EMISSION-COMPUTED; VASOSPASM, INTRACRANIAL;

EID: 84922774022     PISSN: 09675868     EISSN: 15322653     Source Type: Journal    
DOI: 10.1016/j.jocn.2014.06.004     Document Type: Article

References (40)

1. Kassell N, Sasaki T, Colohan A, et al. Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 1985;16:562-72.
2. Athar MK, Levine JM. Treatment options for cerebral vasospasm in aneurysmal subarachnoid hemorrhage. Neurotherapeutics 2012;9:37-43.
3. Hunt WE, Hess RM. Surgical risk as related to the time of intervention in the repair of intracranial aneurysms. J Neurosurg 1968;28:14-20.
4. Frontera JA, Claassen J, Schmidt JM, et al. Prediction of symptomatic vasospasm after subarachnoid hemorrhage: the modified fisher scale. Neurosurgery 2006;59:21-7 [discussion 21-7].
5. Wilson DA, Nakaji P, Abla AA, et al. A simple and quantitative method to predict symptomatic vasospasm after subarachnoid hemorrhage based on computed tomography: beyond the Fisher scale. Neurosurgery 2012;71:869-75.
6. Lindegaard K-F, Nornes H, Bakke S, et al. Cerebral vasospasm after subarachnoid haemorrhage investigated by means of transcranial Doppler ultrasound. In: Proceedings of the 8th European congress of neurosurgery Barcelona, September 6-11, 1987: Springer; 1988. pp. 81-84.
7. Borth W. Alpha 2-macroglobulin, a multifunctional binding protein with targeting characteristics. FASEB J 1992;6:3345-53.
8. LaMarre J, Wollenberg G, Gonias S, et al. Cytokine binding and clearance properties of proteinase-activated alpha 2-macroglobulins. Lab Invest 1991;65:3-14.
9. Hong CM, Tosun C, Kurland DB, et al. Biomarkers as outcome predictors in subarachnoid hemorrhage-a systematic review. Biomarkers 2014;19:95-108.
10. Dumont AS, Dumont RJ, Chow MM, et al. Cerebral vasospasm after subarachnoid hemorrhage: putative role of inflammation. Neurosurgery 2003;53:123-33 [discussion 133-5].
11. Pedram A, Razandi M, Hu RM, et al. Vasoactive peptides modulate vascular endothelial cell growth factor production and endothelial cell proliferation and invasion. J Biol Chem 1997;272:17097-103.
12. Huang L, Guo H, Cheng M, et al. The kinetic change of the serum angiogenin level in patients with acute cerebral infarction. Eur Neurol 2007;58:224-7.
13. Cronin S, Greenway M, Ennis S, et al. Elevated serum angiogenin levels in ALS. Neurology 2006;67:1833-6.
14. Bicknell R, Vallee BL. Angiogenin stimulates endothelial cell prostacyclin secretion by activation of phospholipase A2. Proc Natl Acad Sci U S A 1989;86:1573-7.
15. Karathanasis SK, Oettgen P, Haddad IA, et al. Structure, evolution, and polymorphisms of the human apolipoprotein A4 gene (APOA4). Proc Natl Acad Sci U S A 1986;83:8457-61.
16. Weinberg RB. Apolipoprotein A-IV polymorphisms and diet-gene interactions. Curr Opin Lipidol 2002;13:125-34.
17. Leung CH, Poon WS, Yu LM, et al. Apolipoprotein E genotype and outcome in aneurysmal subarachnoid hemorrhage. Stroke 2002;33:548-52.
18. Gao J, Wang H, Sheng H, et al. A novel apoE-derived therapeutic reduces vasospasm and improves outcome in a murine model of subarachnoid hemorrhage. Neurocrit Care 2006;4:25-31.
19. Souza LM, Boone TC, Gabrilove J, et al. Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells. Science 1986;232:61-5.
20. Metcalf D. The granulocyte-macrophage colony-stimulating factors. Science 1985;229:16-22.
21. Skeel A, Yoshimura T, Showalter SD, et al. Macrophage stimulating protein: purification, partial amino acid sequence, and cellular activity. J Exp Med 1991;173:1227-34.
22. Wang X, Hankey PA. The ron receptor tyrosine kinase, a key regulator of inflammation and cancer progression. Crit Rev Immunol 2013;33:549-74.
23. Lu Y, Yao HP, Wang MH. Multiple variants of the RON receptor tyrosine kinase: biochemical properties, tumorigenic activities, and potential drug targets. Cancer Lett 2007;257:157-64.
24. Correll P, Iwama A, Tondat S, et al. Deregulated inflammatory response in mice lacking the STK/RON receptor tyrosine kinase. Genes Funct 1997;1:69-83.
25. Imaizumi T, Yagihashi N, Hatakeyama M, et al. Expression of retinoic acidinducible gene-I in vascular smooth muscle cells stimulated with interferongamma. Life Sci 2004;75:1171-80.
26. Libby P. Molecular bases of the acute coronary syndromes. Circulation 1995;91:2844-50.
27. Zaroff JG, Rordorf GA, Ogilvy CS, et al. Regional patterns of left ventricular systolic dysfunction after subarachnoid hemorrhage: evidence for neurally mediated cardiac injury. J Am Soc Echocardiogr 2000;13:774-9.
28. Kono T, Morita H, Kuroiwa T, et al. Left ventricular wall motion abnormalities in patients with subarachnoid hemorrhage: neurogenic stunned myocardium. J Am Coll Cardiol 1994;24:636-40.
29. Nielsen H, Clemmensen L, Kharazmi A. Tetranectin: a novel secretory protein from human monocytes. Scand J Immunol 1993;37:39-42.
30. Clemmensen I, Petersen LC, Kluft C. Purification and characterization of a novel, oligomeric, plasminogen kringle 4 binding protein from human plasma: tetranectin. Eur J Biochem 1986;156:327-33.
31. Wang ES, Sun Y, Guo JG, et al. Tetranectin and apolipoprotein A-I in cerebrospinal fluid as potential biomarkers for Parkinson's disease. Acta Neurol Scand 2010;122:350-9.
32. Arellano-Garcia ME, Li R, Liu X, et al. Identification of tetranectin as a potential biomarker for metastatic oral cancer. Int J Mol Sci 2010;11:3106-21.
33. Tammela T, Zarkada G, Wallgard E, et al. Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation. Nature 2008;454:656-60.
34. Borel CO, McKee A, Parra A, et al. Possible role for vascular cell proliferation in cerebral vasospasm after subarachnoid hemorrhage. Stroke 2003;34:427-33.
35. Carriero MV, Del Vecchio S, Capozzoli M, et al. Urokinase receptor interacts with alpha(v)beta5 vitronectin receptor, promoting urokinase-dependent cell migration in breast cancer. Cancer Res 1999;59:5307-14.
36. Posey JA, Khazaeli M, DelGrosso A, et al. A pilot trial of Vitaxin, a humanized anti-vitronectin receptor (anti alpha v beta 3) antibody in patients with metastatic cancer. Cancer Biother Radiopharm 2001;16:125-32.
37. Lafrenie RM, Podor TJ, Buchanan MR, et al. Up-regulated biosynthesis and expression of endothelial cell vitronectin receptor enhances cancer cell adhesion. Cancer Res 1992;52:2202-8.
38. Brown SL, Lundgren CH, Nordt T, et al. Stimulation of migration of human aortic smooth muscle cells by vitronectin: implications for atherosclerosis. Cardiovasc Res 1994;28:1815-20.
39. Fukata Y, Amano M, Kaibuchi K, et al. Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells. Trends Pharmacol Sci 2001;22:32-9.
40. Findlay JM, Weir BK, Kanamaru K, et al. Arterial wall changes in cerebral vasospasm. Neurosurgery 1989;25:736-45 [discussion 745-6].